Showing results (401-410 of 666) with videos related to
Sort By:
Pageof 67
Journal of Molecular Biology|March 10, 2001
Identification of the domain in the human interleukin-11 receptor that mediates ligand bindingK Schleinkofer, A Dingley, I Tacken, et al.FEBS Letters|November 5, 1984
Induction of rat alpha 2-macroglobulin in vivo and in hepatocyte primary cultures: synergistic action of glucocorticoids and a Kupffer cell-derived factorJ Bauer, M Birmelin, G H Northoff, et al.Journal of Cell Science|August 30, 2007
Nucleocytoplasmic shuttling of persistently activated STAT3Andreas Herrmann, Michael Vogt, Martin Mönnigmann, et al.Cancer Research|October 7, 2004
Inhibition of gp130 signaling in breast cancer blocks constitutive activation of Stat3 and inhibits in vivo malignancyKatri S Selander, Li Li, Latania Watson, et al.Journal of Immunology (Baltimore, Md. : 1950)|February 24, 2009
An unusual insertion in Jak2 is crucial for kinase activity and differentially affects cytokine responsesClaude Haan, Daniela C Kroy, Stefan Wüller, et al.European Journal of Immunology|February 1, 1993
The soluble interleukin-6 receptor is generated by sheddingJ Müllberg, H Schooltink, T Stoyan, et al.European Journal of Biochemistry|December 1, 1995
Expression of a biologically active murine tissue inhibitor of metalloproteinases-1 (TIMP-1) in baculovirus-infected insect cells. Purification and tissue distribution in the ratP Kurschat, L Graeve, A Erren, et al.Journal of Immunology (Baltimore, Md. : 1950)|January 8, 2008
Dual role of the Jak1 FERM and kinase domains in cytokine receptor binding and in stimulation-dependent Jak activationSerge Haan, Christiane Margue, Arnaud Engrand, et al.Critical Care Medicine|December 12, 2003
Intrahepatic synthesis of tumor necrosis factor-alpha related to cardiac surgery is inhibited by interleukin-10 via the Janus kinase (Jak)/signal transducers and activator of transcription (STAT) pathwayMa Qing, Ariane Nimmesgern, Peter C Heinrich, et al.HPB : the Official Journal of the International Hepato Pancreato Biliary Association|December 20, 2021
Hepatic metastases in gastrointestinal stromal tumors: oncologic outcomes with curative-intent hepatectomy, resection of treatment-resistant disease, and tyrosine kinase inhibitor therapy aloneThomas L Sutton, Brett S Walker, Kevin G Billingsley, et al.Pageof 67